fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Darnitsa is the first Ukrainian company to join The Regulatory Affairs Professionals Society

08/ 02/ 2021
  February 1, 2021, Kyiv. Darnitsa Pharmaceutical Company has become a member of The Regulatory Affairs Professionals Society (RAPS) - the worlds largest organization of specialists in regulation of healthcare and related products (medicines, medical devices, biologics and food products). RAPS is headquartered in the United States near Washington, D.C., with offices and affiliates around the world. As part of participation in the global network Darnitsa is going to concentrate on advancing and enhancing the standards for documents preparation, conducting clinical tests, ensuring the quality and acceptance of medications in the market and monitoring their usage. Oleksandr Torhun, director in regulatory issues of the pharmaceutical company Darnitsa: In an emergency situation in the global healthcare system caused by the pandemic COVID-19, the regulatory specialists have faced new challenges in all countries of the world. RAPS has the necessary resources to tackle the challenges. Joining the Society, Darnitsa has received new opportunities to improve professional competencies in this area. We have obtained additional tools to expand accessibility of safe and effective medical treatment, namely by increasing the standards of work in the regulatory sphere. Founded in 1976, RAPS is a non-profit organization that develops professional standards in the field of regulation, conducts research, promotes knowledge-sharing and networking, and conducts certification of specialists (RAC).

February 1, 2021, Kyiv. Darnitsa Pharmaceutical Company has become a member of The Regulatory Affairs Professionals Society (RAPS) – the world’s largest organization of specialists in regulation of healthcare and related products (medicines, medical devices, biologics and food products). RAPS is headquartered in the United States near Washington, D.C., with offices and affiliates around the world.

As part of participation in the global network “Darnitsa” is going to concentrate on advancing and enhancing the standards for documents preparation, conducting clinical tests, ensuring the quality and acceptance of medications in the market and monitoring their usage.

Oleksandr Torhun, director in regulatory issues of the pharmaceutical company “Darnitsa”:
“In an emergency situation in the global healthcare system caused by the pandemic COVID-19, the regulatory specialists have faced new challenges in all countries of the world.” RAPS has the necessary resources to tackle the challenges. Joining the Society, “Darnitsa” has received new opportunities to improve professional competencies in this area. We have obtained additional tools to expand accessibility of safe and effective medical treatment, namely by increasing the standards of work in the regulatory sphere.

Founded in 1976, RAPS is a non-profit organization that develops professional standards in the field of regulation, conducts research, promotes knowledge-sharing and networking, and conducts certification of specialists (RAC).

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks
0 Shares

Spelling error report

The following text will be sent to our editors: